Results 171 to 180 of about 57,488 (195)

The implications of IDH mutations for cancer development and therapy

Nature Reviews Clinical Oncology, 2021
Hai Yan, Hai Yan, Christopher J Pirozzi
exaly  

IDH Snippets

2017
P. Anandan, Vidya Natampally, Srinivasa Ranganathan   +2 more
openaire   +1 more source

Glioblastoma IDH wildtype - multifocal

2023
openaire   +1 more source

IDH Mutations in Glioma: Double-Edged Sword in Clinical Applications?

Biomedicines, 2021
Alisan Kayabolen, Ebru Yılmaz, Tuğba Bağcı-Önder   +2 more
exaly  

From Laboratory Studies to Clinical Trials: Temozolomide Use in IDH-Mutant Gliomas

Cells, 2021
Sevin Turcan
exaly  

Infratentorial IDH-mutant astrocytoma is a distinct subtype

Acta Neuropathologica, 2020
Felix Sahm, Patrick N. Harter, Bujung Hong   +2 more
exaly  

Novel, improved grading system(s) for IDH-mutant astrocytic gliomas

Acta Neuropathologica, 2018
Felix Sahm, Michael Platten
exaly  

Diffuse gliomas in patients aged 55 years or over: A suggestion for IDH mutation testing

Neuropathology, 2020
Valeria Barresi, Giuseppe K Ricciardi, Michele Simbolo   +2 more
exaly  

IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas

Acta Neuropathologica, 2015
Pieter Wesseling, Adriana Olar, Bauke Ylstra   +2 more
exaly  

Prognostic significance of IDH mutation in adult low-grade gliomas: a meta-analysis

Journal of Neuro-Oncology, 2013
Song Han, Changxiang Yan, Hairui Sun
exaly